9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium

✍ Scribed by Hedy L. Kindler; Anjali Avadhani; Kurombi Wade-Oliver; Theodore Karrison; Sridhar Mani; Everett E. Vokes

• Book ID: 111579913
• Publisher: Springer US
• Year: 2004
• Tongue: English
• Weight: 56 KB
• Volume: 22
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1023/b:drug.0000026259.28395.c2